Treating hypertension with single pill combinations: a simple strategy to save costs for the patients and payers.

ABSTRACT:

Objectives

Our aim was to compare direct costs for single pill combinations (SPCs) and free-drug combinations for hypertension treatment.

Methods

We focused on Australia as a case study and reviewed total costs, and for the patient and government. We reviewed the Australian "Pharmaceutical Benefits Scheme item drug map" considering different thresholds for the government safety net. Total costs included medicine costs and pharmacy fees.

Results

For patients, SPCs always cost less than free-drug combinations, with greatest savings for general patients before reaching safety net (averaging 30%). For government, SPCs cost on average less than free-drug combinations, for Concession Card holders both before (averaging 11%) and after reaching safety net (averaging 26%) and

SUBMITTER: Pikkemaat M 

PROVIDER: S-EPMC12337932 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature